Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00663273|
Recruitment Status : Completed
First Posted : April 22, 2008
Last Update Posted : January 8, 2009
|Condition or disease||Intervention/treatment||Phase|
|Hygiene||Drug: Lactic acid (Dermacid)||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||30 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower|
|Study Start Date :||December 2007|
|Actual Primary Completion Date :||January 2008|
Lactic acid in small quantity during 21 days.
Drug: Lactic acid (Dermacid)
Liquid soup to be applied in the external genital area, in a small quantity, with abundantly rinse after use, during 21 days.
- Adverse events and their intensity and their association with the treatment. [ Time Frame: 21 days ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00663273
|São Paulo, Brazil|
|Study Director:||Jaderson Lima||Sanofi-aventis administrative office Brazil|